TerSera Therapeutics LLC recalls Zoladex
- Recalling company
- TerSera Therapeutics LLC
- Product
- Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.
- Reason
- Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Aug 31, 2026
- Reported
- Oct 7, 2026
- Distribution
- USA Nationwide
- Status
- Ongoing
- Quantity
- 296 cartons
- Lot / codes
- Lot#: YN0099, Exp 01/31/2028
- Company location
- Deerfield, IL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0875-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0875-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.